Loading...
Loading...
Dr. Reddy's Laboratories
RDY announced today that is has
launched Finasteride Tablets (1 mg), a bioequivalent generic version of
Propecia® (Finasteride) Tablets in the US market on January 02, 2013.
Dr. Reddy's ANDA for Finasteride 1 mg Tablets has been awarded a 180-day
period of marketing exclusivity in the U.S. on 2 Jan, 2013.
The Propecia® Tablets brand has U.S. sales of approximately $136 Million
MAT for the most recent twelve months ending in October 2012 according
to IMS Health*.
Dr. Reddy's Finasteride Tablets 1 mg is available in bottle counts of 30
and 90.
Disclaimer
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in